Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
An unexpected role for the brain in the pathogenesis of diabetic ketoacidosis
Zaman Mirzadeh, Gregory J. Morton, Irl B. Hirsch, Michael W. Schwartz
Zaman Mirzadeh, Gregory J. Morton, Irl B. Hirsch, Michael W. Schwartz
View: Text | PDF
Viewpoint

An unexpected role for the brain in the pathogenesis of diabetic ketoacidosis

  • Text
  • PDF
Abstract

Authors

Zaman Mirzadeh, Gregory J. Morton, Irl B. Hirsch, Michael W. Schwartz

×

Figure 1

Opposing roles of brain and pancreas in the control of fuel mobilization.

Options: View larger image (or click on image) Download as PowerPoint
Opposing roles of brain and pancreas in the control of fuel mobilization...
(A) Under fed conditions, fuel mobilization is inhibited both by the action of leptin in the brain and by the inhibitory effect of insulin (secreted by pancreatic β cells) on liver and adipose tissue. HPA, hypothalamic-pituitary-adrenal; GH, growth hormone. (B–D) In the fasted state (B), low leptin levels trigger multiple neuroendocrine and autonomic mechanisms (secretion of glucagon, increased sympathetic outflow) to promote mobilization of fuels — primarily, glucose and ketones from the liver and FFAs and glycerol from adipose tissue. These responses are constrained by insulin. In T1D (C), severe insulin deficiency causes leptin deficiency and eliminates the normal brake on fuel mobilization. Brain perception of fuel depletion therefore triggers fuel mobilization that is unopposed by either the central action of leptin or the peripheral action of insulin, leading to progressive hyperglycemia and DKA. By blocking the perception of fuel deficiency, leptin delivery directly into the brain (D) restores circulating fuel levels to normal, despite ongoing, severe insulin deficiency.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts